Condition: HAP - Hospital Acquired Pneumonia · VAP - Ventilator Associated Pneumonia · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Multicenter, randomized, controlled, open-label trial to assess if semiquantitative multiplex PCR assay, as compared to conventional microbiology, can reduce the percentage of patients without microbiological diagnosis in the first 24 hours from HAP/VAP suspicion, thus allowing early de-escalation.
This description comes directly from the study's public registry record.
Gennaro De Pascale, MD · +393208998173 · gennaro.depascale@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| S. Orsola Research Hospital | Bologna, Italy | Not Yet Recruiting |
| Ospedale Careggi | Florence, Italy | Not Yet Recruiting |
| Modena Policlinico | Modena, Italy | Not Yet Recruiting |
| Fondazione Policlinico Universitario "A. GEMELLI" IRCCS | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05952648